Table 2.
Descriptive analysis of liver function tests in GIBIEX Study. Stratification of pathological vs normal reports by group of treatment
| Liver function test | IDN 5933 N 27 | Placebo N 20 |
|---|---|---|
| Aspartate Aminotransferase [AST] | ||
| T0 | ||
| Normal | 26 | 20 |
| Pathological | 1 | 0 |
| T1 | ||
| Normal | 27 | 20 |
| Pathological | 0 | 0 |
| Alanine Aminotransferase [ALT] | ||
| T0 | ||
| Normal | 26 | 20 |
| Pathological | 1 | |
| T1 | ||
| Normal | 27 | 20 |
| Pathological | 0 | 0 |
| Gamma Glutamyl Transferase [γGT] | ||
| T0 | ||
| Normal | 23 | 18 |
| Pathological | 4 | 2 |
| T1 | ||
| Normal | 23 | 18 |
| Pathological | 4 | 2 |